CNS Pharmaceuticals, Inc. (CNSP)
NASDAQ: CNSP · Real-Time Price · USD
6.60
+0.09 (1.38%)
At close: Dec 5, 2025, 4:00 PM EST
6.55
-0.05 (-0.76%)
After-hours: Dec 5, 2025, 7:09 PM EST

CNS Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Market Capitalization
47732040
Upgrade
Market Cap Growth
-43.84%4.40%109.26%-83.83%-51.07%-37.41%
Upgrade
Enterprise Value
-6-06-41139
Upgrade
Last Close Price
6.6072.2438100.0472000.07632166.321602016.02
Upgrade
PB Ratio
0.381.12-1.500.393.182.87
Upgrade
P/TBV Ratio
0.411.12-0.393.182.87
Upgrade
Debt / Equity Ratio
0.000.05-0.070.050.060.03
Upgrade
Quick Ratio
5.042.910.092.041.937.37
Upgrade
Current Ratio
5.823.430.262.552.888.13
Upgrade
Return on Equity (ROE)
-197.11%-1703.39%-1018.78%-213.68%-144.15%-87.78%
Upgrade
Return on Assets (ROA)
-85.59%-179.08%-159.83%-87.50%-73.58%-49.73%
Upgrade
Return on Capital (ROIC)
-123.84%-785.51%-534.54%-126.44%-86.48%-53.75%
Upgrade
Return on Capital Employed (ROCE)
-133.20%-241.30%425.60%-187.70%-235.00%-67.80%
Upgrade
Earnings Yield
-319.28%-214.67%-284.36%-482.14%-73.97%-23.61%
Upgrade
FCF Yield
-396.55%-247.31%-213.35%-333.40%-69.11%-18.32%
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q